{"transactions":[{"id":1296529,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-01-23T16:35:11.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":283101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on January 21, 2026, after which 1/48 of the option will become exercisable on the 21st of each month through  January 21, 2029."}],"balance_after":283101,"derivative":{"exercise_price":4.56,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":283101},"source":{"system":"sec-edgar","filing":"0001818382-25-000021","document":"wk-form4_1737668104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838225000021/wk-form4_1737668104.xml","form_type":"4"}},{"id":1324314,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2024-12-20T17:09:22.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 14, 2020, Humacyte granted options to purchase 2,625 shares of common stock, which vested as follows: (i) one-fifth on the first anniversary of the vesting commencement date, (ii) two-fifths in equal installments over a period of 24 months commencing on the first anniversary of the vesting commencement date, (iii) one-fifth upon the submission of a Biologics License Application (\"BLA\") to the FDA and (iv) one-fifth upon FDA approval of one of Humacyte's product candidates. Humacyte previously reported three-fifths of the option grant on a Form 4 filed on August 27, 2021 and one-fifth of the option grant on a Form 4 filed on December 12, 2023. On December 19, 2024, Humacyte received FDA approval for its acellular tissue engineered vessel product candidate for an indication in vascular trauma. Accordingly, columns 5 and 7 of Table II report the number of securities equal to the final one-fifth of the 12/14/2020 option grant."}],"balance_after":2625,"derivative":{"exercise_price":10.28,"exercise_date":"2024-12-19","expiration_date":"2030-12-14","underlying":"Common Stock","underlying_shares":525},"source":{"system":"sec-edgar","filing":"0001818382-24-000229","document":"wk-form4_1734732556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838224000229/wk-form4_1734732556.xml","form_type":"4"}},{"id":1495361,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2024-06-03T16:23:27.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":false,"shares":48166,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":87834,"derivative":{"exercise_price":3.07,"exercise_date":"2024-05-08","expiration_date":"2032-12-08","underlying":"Common Stock","underlying_shares":48166},"source":{"system":"sec-edgar","filing":"0001818382-24-000074","document":"wk-form4_1717446198.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838224000074/wk-form4_1717446198.xml","form_type":"4"}},{"id":1495360,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2024-06-03T16:23:27.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":false,"shares":78779,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.56,"exercise_date":"2018-12-11","expiration_date":"2025-12-11","underlying":"Common Stock","underlying_shares":78779},"source":{"system":"sec-edgar","filing":"0001818382-24-000074","document":"wk-form4_1717446198.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838224000074/wk-form4_1717446198.xml","form_type":"4"}},{"id":1495359,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-06-03T16:23:27.000Z","date":"2024-05-31","kind":"sale","planned":false,"acquired":false,"shares":2625,"price":9.412,"value":24706.5,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001818382-24-000074","document":"wk-form4_1717446198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838224000074/wk-form4_1717446198.xml","form_type":"4"}},{"id":1495358,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-06-03T16:23:27.000Z","date":"2024-05-30","kind":"sale","planned":false,"acquired":false,"shares":48166,"price":8.32,"value":400741.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.31 to $8.42. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2625,"source":{"system":"sec-edgar","filing":"0001818382-24-000074","document":"wk-form4_1717446198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838224000074/wk-form4_1717446198.xml","form_type":"4"}},{"id":1495357,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-06-03T16:23:27.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":true,"shares":48166,"price":3.07,"value":147869.62,"ownership":{"direct":true},"balance_after":50791,"source":{"system":"sec-edgar","filing":"0001818382-24-000074","document":"wk-form4_1717446198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838224000074/wk-form4_1717446198.xml","form_type":"4"}},{"id":1495356,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-06-03T16:23:27.000Z","date":"2024-05-30","kind":"sale","planned":false,"acquired":false,"shares":78779,"price":8.36,"value":658592.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.36 to $8.44. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2625,"source":{"system":"sec-edgar","filing":"0001818382-24-000074","document":"wk-form4_1717446198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838224000074/wk-form4_1717446198.xml","form_type":"4"}},{"id":1495355,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-06-03T16:23:27.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":true,"shares":78779,"price":2.56,"value":201674.24,"ownership":{"direct":true},"balance_after":81404,"source":{"system":"sec-edgar","filing":"0001818382-24-000074","document":"wk-form4_1717446198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838224000074/wk-form4_1717446198.xml","form_type":"4"}},{"id":1495354,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-06-03T16:23:27.000Z","date":"2024-05-30","kind":"sale","planned":false,"acquired":false,"shares":61941,"price":7.71,"value":477565.11,"ownership":{"direct":true},"balance_after":2625,"source":{"system":"sec-edgar","filing":"0001818382-24-000074","document":"wk-form4_1717446198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838224000074/wk-form4_1717446198.xml","form_type":"4"}},{"id":1714558,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-12-12T16:10:20.000Z","date":"2023-12-11","kind":"grant","planned":false,"acquired":true,"shares":525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 14, 2020, Humacyte granted options to purchase 2,625 shares of common stock, which vest as follows: (i) one-fifth on the first anniversary of the vesting commencement date, (ii) two-fifths in equal installments over a period of 24 months commencing on the first anniversary of the vesting commencement date, (iii) one-fifth upon the submission of a Biologics License Application (\"BLA\") to the FDA and (iv) one-fifth upon FDA approval of one of Humacyte's product candidates. Humacyte previously reported three-fifths of the option grant on a Form 4 filed on August 27, 2021. On December 11, 2023 Humacyte submitted a BLA to the FDA. Accordingly, columns 5 and 7 of Table II report the number of securities equal to one-fifth of the 12/14/2020 option grant."}],"balance_after":2100,"derivative":{"exercise_price":10.28,"exercise_date":"2023-12-11","expiration_date":"2030-12-14","underlying":"Common Stock","underlying_shares":525},"source":{"system":"sec-edgar","filing":"0001818382-23-000196","document":"wk-form4_1702415411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838223000196/wk-form4_1702415411.xml","form_type":"4"}},{"id":1714557,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-12-12T16:10:20.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on December 8, 2024, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2027."}],"balance_after":290000,"derivative":{"exercise_price":2.8,"expiration_date":"2033-12-08","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001818382-23-000196","document":"wk-form4_1702415411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838223000196/wk-form4_1702415411.xml","form_type":"4"}},{"id":1876767,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-05-26T17:05:09.000Z","date":"2023-05-25","kind":"exercise","planned":false,"acquired":false,"shares":64990,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.19,"exercise_date":"2016-11-22","expiration_date":"2023-11-22","underlying":"Common Stock","underlying_shares":64990},"source":{"system":"sec-edgar","filing":"0001104659-23-065547","document":"tm2317123-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465923065547/tm2317123-10_4seq1.xml","form_type":"4"}},{"id":1876766,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-05-26T17:05:09.000Z","date":"2023-05-24","kind":"exercise","planned":false,"acquired":false,"shares":13789,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64990,"derivative":{"exercise_price":1.19,"exercise_date":"2016-11-22","expiration_date":"2023-11-22","underlying":"Common Stock","underlying_shares":13789},"source":{"system":"sec-edgar","filing":"0001104659-23-065547","document":"tm2317123-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465923065547/tm2317123-10_4seq1.xml","form_type":"4"}},{"id":1876765,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-05-26T17:05:09.000Z","date":"2023-05-25","kind":"sale","planned":false,"acquired":false,"shares":9613,"price":3.83,"value":36817.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.82 to $3.89. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":64566,"source":{"system":"sec-edgar","filing":"0001104659-23-065547","document":"tm2317123-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465923065547/tm2317123-10_4seq1.xml","form_type":"4"}},{"id":1876764,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-05-26T17:05:09.000Z","date":"2023-05-25","kind":"exercise","planned":false,"acquired":true,"shares":64990,"price":1.19,"value":77338.1,"ownership":{"direct":true},"balance_after":74179,"source":{"system":"sec-edgar","filing":"0001104659-23-065547","document":"tm2317123-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465923065547/tm2317123-10_4seq1.xml","form_type":"4"}},{"id":1876763,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-05-26T17:05:09.000Z","date":"2023-05-24","kind":"sale","planned":false,"acquired":false,"shares":13789,"price":4.14,"value":57086.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.14 to $4.16. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9189,"source":{"system":"sec-edgar","filing":"0001104659-23-065547","document":"tm2317123-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465923065547/tm2317123-10_4seq1.xml","form_type":"4"}},{"id":1876762,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-05-26T17:05:09.000Z","date":"2023-05-24","kind":"exercise","planned":false,"acquired":true,"shares":13789,"price":1.19,"value":16408.91,"ownership":{"direct":true},"balance_after":22978,"source":{"system":"sec-edgar","filing":"0001104659-23-065547","document":"tm2317123-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465923065547/tm2317123-10_4seq1.xml","form_type":"4"}},{"id":2088222,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-13T16:06:59.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":6564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.15,"exercise_date":"2015-12-14","expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":6564},"source":{"system":"sec-edgar","filing":"0001818382-22-000203","document":"wf-form4_167096559281877.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838222000203/wf-form4_167096559281877.xml","form_type":"4"}},{"id":2088221,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-12-13T16:06:59.000Z","date":"2022-12-12","kind":"exercise","acquired":true,"shares":6564,"price":1.15,"value":7548.6,"ownership":{"direct":true},"balance_after":9189,"source":{"system":"sec-edgar","filing":"0001818382-22-000203","document":"wf-form4_167096559281877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838222000203/wf-form4_167096559281877.xml","form_type":"4"}},{"id":2089933,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-12T16:14:26.000Z","date":"2022-12-08","kind":"grant","acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026."}],"balance_after":136000,"derivative":{"exercise_price":3.07,"expiration_date":"2032-12-08","underlying":"Common Stock","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001818382-22-000199","document":"wf-form4_167087964180804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000181838222000199/wf-form4_167087964180804.xml","form_type":"4"}},{"id":2588547,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-08-27T16:09:43.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":1575,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As part of the Business Combination, each Legacy Humacyte stock option was exchanged for a stock option to acquire 0.2626 shares of common stock of Humacyte, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to purchase 2,625 shares of Common Stock granted on 12/14/2020, which vest as follows: (i) one-fifth on the first anniversary of the vesting commencement date, (ii) two-fifths in equal installments over a period of 24 months commencing on the first anniversary of the vesting commencement date, (iii) one-fifth upon the submission of a Biologics License Application to the FDA and (iv) one-fifth upon FDA approval of one of Humacyte's product candidates. Accordingly, columns 5, 7, and 9 of Table II report the number of securities equal to three-fifths of the 12/14/2020 option grant."}],"balance_after":1575,"derivative":{"exercise_price":10.28,"exercise_date":"2021-12-14","expiration_date":"2030-12-14","underlying":"Common Stock","underlying_shares":1575},"source":{"system":"sec-edgar","filing":"0001104659-21-110525","document":"tm2125954-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465921110525/tm2125954-16_4seq1.xml","form_type":"4"}},{"id":2588546,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-08-27T16:09:43.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":157558,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As part of the Business Combination, each Legacy Humacyte stock option was exchanged for a stock option to acquire 0.2626 shares of common stock of Humacyte, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options are fully vested and exercisable."}],"balance_after":157558,"derivative":{"exercise_price":6.54,"expiration_date":"2028-04-12","underlying":"Common Stock","underlying_shares":157558},"source":{"system":"sec-edgar","filing":"0001104659-21-110525","document":"tm2125954-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465921110525/tm2125954-16_4seq1.xml","form_type":"4"}},{"id":2588545,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-08-27T16:09:43.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":78779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As part of the Business Combination, each Legacy Humacyte stock option was exchanged for a stock option to acquire 0.2626 shares of common stock of Humacyte, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options are fully vested and exercisable."}],"balance_after":78779,"derivative":{"exercise_price":2.56,"expiration_date":"2025-12-11","underlying":"Common Stock","underlying_shares":78779},"source":{"system":"sec-edgar","filing":"0001104659-21-110525","document":"tm2125954-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465921110525/tm2125954-16_4seq1.xml","form_type":"4"}},{"id":2588544,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-08-27T16:09:43.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":78779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As part of the Business Combination, each Legacy Humacyte stock option was exchanged for a stock option to acquire 0.2626 shares of common stock of Humacyte, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options are fully vested and exercisable."}],"balance_after":78779,"derivative":{"exercise_price":1.19,"expiration_date":"2023-11-22","underlying":"Common Stock","underlying_shares":78779},"source":{"system":"sec-edgar","filing":"0001104659-21-110525","document":"tm2125954-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465921110525/tm2125954-16_4seq1.xml","form_type":"4"}},{"id":2588543,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-08-27T16:09:43.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":6564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As part of the Business Combination, each Legacy Humacyte stock option was exchanged for a stock option to acquire 0.2626 shares of common stock of Humacyte, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options are fully vested and exercisable."}],"balance_after":6564,"derivative":{"exercise_price":1.15,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":6564},"source":{"system":"sec-edgar","filing":"0001104659-21-110525","document":"tm2125954-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465921110525/tm2125954-16_4seq1.xml","form_type":"4"}},{"id":2588542,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83932,"kind":"person","name":"Prichard Heather Ledbetter","position":1,"cik":"0001877712","reported_name":"Prichard Heather Ledbetter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-08-27T16:09:43.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":2625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 26, 2021 , Alpha Health care Acquisition Corp. (\"AHAC\") consummated a business combination (the \"Business Combination\") by and among AHAC, Hunter Merger Sub, Inc., a Delaware corporation (\"Hunter Merger Sub\" ) and Humacyte, Inc., a Delaware corporation (\"Legacy Humacyte\"), AHAC changed its name to \"Humacyte, Inc.\" and Hunter Merger Sub merged with and into Legacy Humacyte. As part of the Business Combination, each share of Legacy Humacyte stock was exchanged for 0.2626 shares of common stock of Humacyte, Inc."}],"balance_after":2625,"source":{"system":"sec-edgar","filing":"0001104659-21-110525","document":"tm2125954-16_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877712/000110465921110525/tm2125954-16_4seq1.xml","form_type":"4"}}]}